サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451604

無細胞タンパク質発現市場レポート：製品、方法、用途、エンドユーザー、地域別、2024-2032

Cell-free Protein Expression Market Report by Product, Method, Application, End User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 144 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
無細胞タンパク質発現市場レポート：製品、方法、用途、エンドユーザー、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の無細胞タンパク質発現市場規模は、2023年に2億6,530万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに4億8,770万米ドルに達し、2024年から2032年の間に6.86%の成長率（CAGR）を示すと予測しています。

無細胞タンパク質発現（CFPE）とは、細胞から抽出した生体分子翻訳装置を用いて、溶液中で目的の組換えタンパク質を生産することを指します。CFPEは、大腸菌、ウサギ網状赤血球、小麦胚芽、昆虫細胞、哺乳類無細胞タンパク質発現系など、さまざまな細胞溶解物を用いて実施できます。CFPEは、酵素工学、タンパク質標識、タンパク質精製、タンパク質間相互作用、変異体のハイスループット生産などに広く用いられています。CFPEはまた、タンパク質の安定性、分解、フォールディングに必要な成分の分析にも用いられます。細胞ベースのタンパク質発現と比較すると、無細胞タンパク質発現は時間効率が高く便利で、非天然アミノ酸の組み込みが可能で、安定性と特異性が向上します。

無細胞タンパク質発現市場の動向：

生物科学の急速な進歩は、市場成長を促進する重要な要因の一つです。無細胞タンパク質発現は、遺伝暗号の拡張、ウイルスの組み立て、様々な生体分子プロセスのための組換えタンパク質の合成に広く使用されています。さらに、がんや感染症を治療するための抗体、抗菌薬、サイトカインなどのタンパク質ベースの治療薬を開発するための製薬業界における技術利用の増加は、別の成長促進要因として作用しています。さらに、効率的なプロトタイピングとハイスループット実験のためにシステムを最適化することで、タンパク質生産収率を向上させる機械学習（ML）アルゴリズムの統合が、市場成長の原動力となっています。さらに、連続交換無細胞（CECF）タンパク質合成システムを使用して複雑な原核生物および真核生物タンパク質を生産するための新規プロセスの導入は、市場に明るい見通しを生み出しています。その他の要因としては、バイオ製造やプロトタイピングにおける無細胞法の広範な採用、プロテオミクスやゲノミクスにおける広範な研究開発（R&D）活動、病原体感知、炎症反応、個別化医療などの診断用途におけるヘルスケア業界での採用の高まりなどがあり、市場の成長を後押ししています。

本レポートで扱う主な質問

  • 2023年の無細胞タンパク質発現の世界市場規模は？
  • 2024-2032年の世界の無細胞タンパク質発現市場の予想成長率は？
  • 無細胞タンパク質発現の世界市場を牽引する主要因は何か？
  • 無細胞タンパク質発現の世界市場におけるCOVID-19の影響は？
  • 無細胞タンパク質発現の世界市場における製品別の区分は？
  • 無細胞タンパク質発現の世界市場における方法別の区分は？
  • 無細胞タンパク質発現の世界市場の用途別区分は？
  • 無細胞タンパク質発現の世界市場のエンドユーザー別の区分は？
  • 無細胞タンパク質発現の世界市場における主要地域は？
  • 無細胞タンパク質発現の世界市場における主要プレイヤー/企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の無細胞タンパク質発現市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 発現システム
    • 市場動向
    • 主要セグメント
      • 大腸菌無細胞タンパク質発現システム
      • 小麦胚芽無細胞タンパク質発現システム
      • ウサギ網状赤血球無細胞タンパク質発現システム
      • 昆虫細胞無細胞タンパク質発現システム
      • ヒト無細胞タンパク質発現システム
      • その他
    • 市場予測
  • 試薬
    • 市場動向
    • 市場予測

第7章 市場内訳：方法別

  • 転写・翻訳システム
    • 市場動向
    • 市場予測
  • 翻訳システム
    • 市場動向
    • 市場展望

第8章 市場内訳：用途別

  • 酵素工学
    • 市場動向
    • 市場予測
  • ハイスループット生産
    • 市場動向
    • 市場予測
  • タンパク質ラベリング
    • 市場動向
    • 市場予測
  • タンパク質間相互作用
    • 市場動向
    • 市場予測
  • タンパク質精製
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 製薬・バイオ企業
    • 市場動向
    • 市場予測
  • 学術・研究機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bioneer Corporation
    • biotechrabbit GmbH
    • Cambridge Isotope Laboratories Inc.（Otsuka Pharmaceutical Co. Ltd.）
    • CellFree Sciences Co. Ltd.
    • Cube Biotech GmbH
    • GeneCopoeia Inc.
    • Jena Bioscience GmbH
    • Merck KGaA
    • New England Biolabs
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Cell-free Protein Expression Market: Major Drivers and Challenges
  • Figure 2: Global: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Cell-free Protein Expression Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Cell-free Protein Expression Market: Breakup by Method (in %), 2023
  • Figure 6: Global: Cell-free Protein Expression Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Cell-free Protein Expression Market: Breakup by End User (in %), 2023
  • Figure 8: Global: Cell-free Protein Expression Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Cell-free Protein Expression (Expression Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Cell-free Protein Expression (Expression Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Cell-free Protein Expression (Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Cell-free Protein Expression (Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Cell-free Protein Expression (Transcription and Translation Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Cell-free Protein Expression (Transcription and Translation Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Cell-free Protein Expression (Translation Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Cell-free Protein Expression (Translation Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Cell-free Protein Expression (Enzyme Engineering) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Cell-free Protein Expression (Enzyme Engineering) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Cell-free Protein Expression (High Throughput Production) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Cell-free Protein Expression (High Throughput Production) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Cell-free Protein Expression (Protein Labeling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Cell-free Protein Expression (Protein Labeling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Cell-free Protein Expression (Protein-Protein Interaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Cell-free Protein Expression (Protein-Protein Interaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Cell-free Protein Expression (Protein Purification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Cell-free Protein Expression (Protein Purification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Cell-free Protein Expression (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Cell-free Protein Expression (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Cell-free Protein Expression (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Cell-free Protein Expression (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Cell-free Protein Expression (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Cell-free Protein Expression (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Cell-free Protein Expression Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Cell-free Protein Expression Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Cell-free Protein Expression Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Cell-free Protein Expression Industry: SWOT Analysis
  • Figure 83: Global: Cell-free Protein Expression Industry: Value Chain Analysis
  • Figure 84: Global: Cell-free Protein Expression Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell-free Protein Expression Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Cell-free Protein Expression Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Cell-free Protein Expression Market Forecast: Breakup by Method (in Million US$), 2024-2032
  • Table 4: Global: Cell-free Protein Expression Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Cell-free Protein Expression Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 6: Global: Cell-free Protein Expression Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Cell-free Protein Expression Market: Competitive Structure
  • Table 8: Global: Cell-free Protein Expression Market: Key Players
目次
Product Code: SR112024A6288

The global cell-free protein expression market size reached US$ 265.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 487.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.86% during 2024-2032.

Cell-free protein expression (CFPE) refers to the production of desired recombinant proteins in solution using biomolecular translation machinery extracted from cells. It can be carried out using different cell lysates, such as E. coli, rabbit reticulocytes, wheat germ, insect cells, and mammalian cell-free protein expression systems. They are widely used in enzyme engineering, protein labeling, protein purification, protein-protein interaction, and high throughput production of mutants. CFPE is also used for analyzing components needed for protein stability, degradation, and folding. As compared to cell-based protein expression, cell-free protein expression is time efficient and convenient, allows the incorporation of non-natural amino acids, and provides enhanced stability and specificity.

Cell-free Protein Expression Market Trends:

The rapid advancement in biological sciences is one of the key factors driving the market growth. Cell-free protein expression is extensively used in the expansion of genetic code, assembly of viruses, and the synthesis of recombinant proteins for various biomolecular processes. Furthermore, the increasing technique utilization in the pharmaceutical industry for developing protein-based therapeutics, such as antibodies, antimicrobials, and cytokines, for treating cancer and infectious diseases is acting as another growth-inducing factor. Additionally, the integration of machine learning (ML) algorithms to improve protein production yield by optimizing the system for efficient prototyping and high-throughput experimentation is providing an impetus to market growth. Moreover, the introduction of novel processes to produce complex prokaryotic and eukaryotic proteins using a continuous-exchange cell-free (CECF) protein synthesis system is creating a positive outlook for the market. Other factors, including the widespread adoption of cell-free methods for biomanufacturing and prototyping, extensive research and development (R&D) activities in proteomics and genomics, and the rising adoption in the healthcare industry for diagnostic applications, such as pathogen sensing, inflammatory response, and personalized medicine, are supporting drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cell-free protein expression market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, method, application and end user.

Breakup by Product:

Expression Systems

E. coli Cell-free Protein Expression System

Wheat Germ Cell-free Protein Expression System

Rabbit Reticulocytes Cell-free Protein Expression System

Insect Cells Cell-free Protein Expression System

Human Cell-free Protein Expression System

Others

Reagents

Breakup by Method:

Transcription and Translation Systems

Translation Systems

Breakup by Application:

Enzyme Engineering

High Throughput Production

Protein Labeling

Protein-Protein Interaction

Protein Purification

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Academic and Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioneer Corporation, biotechrabbit GmbH, Cambridge Isotope Laboratories Inc. (Otsuka Pharmaceutical Co. Ltd.), CellFree Sciences Co. Ltd., Cube Biotech GmbH, GeneCopoeia Inc., Jena Bioscience GmbH, Merck KGaA, New England Biolabs, Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global cell-free protein expression market in 2023?
  • 2. What is the expected growth rate of the global cell-free protein expression market during 2024-2032?
  • 3. What are the key factors driving the global cell-free protein expression market?
  • 4. What has been the impact of COVID-19 on the global cell-free protein expression market?
  • 5. What is the breakup of the global cell-free protein expression market based on the product?
  • 6. What is the breakup of the global cell-free protein expression market based on the method?
  • 7. What is the breakup of the global cell-free protein expression market based on application?
  • 8. What is the breakup of the global cell-free protein expression market based on the end user?
  • 9. What are the key regions in the global cell-free protein expression market?
  • 10. Who are the key players/companies in the global cell-free protein expression market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell-free Protein Expression Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Expression Systems
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 E. coli Cell-free Protein Expression System
      • 6.1.2.2 Wheat Germ Cell-free Protein Expression System
      • 6.1.2.3 Rabbit Reticulocytes Cell-free Protein Expression System
      • 6.1.2.4 Insect Cells Cell-free Protein Expression System
      • 6.1.2.5 Human Cell-free Protein Expression System
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Method

  • 7.1 Transcription and Translation Systems
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Translation Systems
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Enzyme Engineering
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 High Throughput Production
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Protein Labeling
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Protein-Protein Interaction
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Protein Purification
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bioneer Corporation
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 biotechrabbit GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Cambridge Isotope Laboratories Inc. (Otsuka Pharmaceutical Co. Ltd.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 CellFree Sciences Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Cube Biotech GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 GeneCopoeia Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Jena Bioscience GmbH
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 New England Biolabs
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Promega Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Takara Bio Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis